• Blok narracyjny
• XML
• JSON
• TTL

: ActiveSubstanceCodeCodeSystem - XML Representation

Active as of 2024-09-17

Raw xml | Download

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="PLActiveSubstanceCodeCodeSystem"/>
  <meta>
    <profile
             value="https://ezdrowie.gov.pl/fhir/StructureDefinition/PLSMPLAdminCodeSystem"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem PLActiveSubstanceCodeCodeSystem</b></p><a name="PLActiveSubstanceCodeCodeSystem"> </a><a name="hcPLActiveSubstanceCodeCodeSystem"> </a><a name="PLActiveSubstanceCodeCodeSystem-pl-PL"> </a><p>This case-sensitive code system <code>https://ezdrowie.gov.pl/fhir/CodeSystem/PLActiveSubstanceCodeCodeSystem</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">larotrektynib<a name="PLActiveSubstanceCodeCodeSystem-larotrektynib"> </a></td><td>Larotrektynib</td></tr><tr><td style="white-space:nowrap">cetuksymab<a name="PLActiveSubstanceCodeCodeSystem-cetuksymab"> </a></td><td>Cetuksymab</td></tr><tr><td style="white-space:nowrap">panitumumab<a name="PLActiveSubstanceCodeCodeSystem-panitumumab"> </a></td><td>Panitumumab</td></tr><tr><td style="white-space:nowrap">adalimumab<a name="PLActiveSubstanceCodeCodeSystem-adalimumab"> </a></td><td>Adalimumab (dostępny w terapii pacjentów od 4 r.ż.)</td></tr><tr><td style="white-space:nowrap">etanercept<a name="PLActiveSubstanceCodeCodeSystem-etanercept"> </a></td><td>Etanercept (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style="white-space:nowrap">infliksymab<a name="PLActiveSubstanceCodeCodeSystem-infliksymab"> </a></td><td>Infliksymab</td></tr><tr><td style="white-space:nowrap">iksekizumab<a name="PLActiveSubstanceCodeCodeSystem-iksekizumab"> </a></td><td>Iksekizumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style="white-space:nowrap">sekukinumab<a name="PLActiveSubstanceCodeCodeSystem-sekukinumab"> </a></td><td>Sekukinumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style="white-space:nowrap">ustekinumab<a name="PLActiveSubstanceCodeCodeSystem-ustekinumab"> </a></td><td>Ustekinumab (dostępny w terapii pacjentów od 6 r.ż.)</td></tr><tr><td style="white-space:nowrap">ryzankizumab<a name="PLActiveSubstanceCodeCodeSystem-ryzankizumab"> </a></td><td>Ryzankizumab</td></tr><tr><td style="white-space:nowrap">guselkumab<a name="PLActiveSubstanceCodeCodeSystem-guselkumab"> </a></td><td>Guselkumab</td></tr><tr><td style="white-space:nowrap">certolizumab_pegol<a name="PLActiveSubstanceCodeCodeSystem-certolizumab_pegol"> </a></td><td>Certolizumab pegol</td></tr><tr><td style="white-space:nowrap">tyldrakizumab<a name="PLActiveSubstanceCodeCodeSystem-tyldrakizumab"> </a></td><td>Tyldrakizumab</td></tr><tr><td style="white-space:nowrap">bimekizumab<a name="PLActiveSubstanceCodeCodeSystem-bimekizumab"> </a></td><td>Bimekizumab</td></tr><tr><td style="white-space:nowrap">esketamina<a name="PLActiveSubstanceCodeCodeSystem-esketamina"> </a></td><td>Esketamina</td></tr><tr><td style="white-space:nowrap">zanubrutynib<a name="PLActiveSubstanceCodeCodeSystem-zanubrutynib"> </a></td><td>Zanubrutynib</td></tr><tr><td style="white-space:nowrap">daratumumab<a name="PLActiveSubstanceCodeCodeSystem-daratumumab"> </a></td><td>Daratumumab</td></tr><tr><td style="white-space:nowrap">entrektynib<a name="PLActiveSubstanceCodeCodeSystem-entrektynib"> </a></td><td>Entrektynib</td></tr><tr><td style="white-space:nowrap">rytuksymab<a name="PLActiveSubstanceCodeCodeSystem-rytuksymab"> </a></td><td>Rytuksymab</td></tr><tr><td style="white-space:nowrap">efgartigimod_alfa<a name="PLActiveSubstanceCodeCodeSystem-efgartigimod_alfa"> </a></td><td>Efgartigimod alfa</td></tr></table></div>
  </text>
  <url
       value="https://ezdrowie.gov.pl/fhir/CodeSystem/PLActiveSubstanceCodeCodeSystem"/>
  <version value="25.0.0"/>
  <name value="PLActiveSubstanceCodeCodeSystem"/>
  <title value="ActiveSubstanceCodeCodeSystem"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2024-09-17T15:37:37+02:00"/>
  <publisher value="CeZ"/>
  <contact>
    <name value="CeZ"/>
    <telecom>
      <system value="url"/>
      <value value="https://ezdrowie.gov.pl"/>
    </telecom>
  </contact>
  <description value="Kody substancji czynnych"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="PL"/>
      <display value="Poland"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="20"/>
  <concept>
    <code value="larotrektynib"/>
    <display value="Larotrektynib"/>
  </concept>
  <concept>
    <code value="cetuksymab"/>
    <display value="Cetuksymab"/>
  </concept>
  <concept>
    <code value="panitumumab"/>
    <display value="Panitumumab"/>
  </concept>
  <concept>
    <code value="adalimumab"/>
    <display value="Adalimumab (dostępny w terapii pacjentów od 4 r.ż.)"/>
  </concept>
  <concept>
    <code value="etanercept"/>
    <display value="Etanercept (dostępny w terapii pacjentów od 6 r.ż.)"/>
  </concept>
  <concept>
    <code value="infliksymab"/>
    <display value="Infliksymab"/>
  </concept>
  <concept>
    <code value="iksekizumab"/>
    <display value="Iksekizumab (dostępny w terapii pacjentów od 6 r.ż.)"/>
  </concept>
  <concept>
    <code value="sekukinumab"/>
    <display value="Sekukinumab (dostępny w terapii pacjentów od 6 r.ż.)"/>
  </concept>
  <concept>
    <code value="ustekinumab"/>
    <display value="Ustekinumab (dostępny w terapii pacjentów od 6 r.ż.)"/>
  </concept>
  <concept>
    <code value="ryzankizumab"/>
    <display value="Ryzankizumab"/>
  </concept>
  <concept>
    <code value="guselkumab"/>
    <display value="Guselkumab"/>
  </concept>
  <concept>
    <code value="certolizumab_pegol"/>
    <display value="Certolizumab pegol"/>
  </concept>
  <concept>
    <code value="tyldrakizumab"/>
    <display value="Tyldrakizumab"/>
  </concept>
  <concept>
    <code value="bimekizumab"/>
    <display value="Bimekizumab"/>
  </concept>
  <concept>
    <code value="esketamina"/>
    <display value="Esketamina"/>
  </concept>
  <concept>
    <code value="zanubrutynib"/>
    <display value="Zanubrutynib"/>
  </concept>
  <concept>
    <code value="daratumumab"/>
    <display value="Daratumumab"/>
  </concept>
  <concept>
    <code value="entrektynib"/>
    <display value="Entrektynib"/>
  </concept>
  <concept>
    <code value="rytuksymab"/>
    <display value="Rytuksymab"/>
  </concept>
  <concept>
    <code value="efgartigimod_alfa"/>
    <display value="Efgartigimod alfa"/>
  </concept>
</CodeSystem>